Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Current Deferred Tax Assets: 2014

  • Avadel Pharmaceuticals' Current Deferred Tax Assets was N/A to $13.1 million in Q4 2014 from the same period last year, while for Dec 2014 it was $13.1 million, marking a year-over-year change of. This contributed to the annual value of $13.1 million for FY2014, which is N/A change from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Current Deferred Tax Assets of $13.1 million as of Q4 2014.
  • Over the past 5 years, Avadel Pharmaceuticals' Current Deferred Tax Assets peaked at $13.1 million during Q4 2014, and registered a low of $13.1 million during Q4 2014.
  • For the 1-year period, Avadel Pharmaceuticals' Current Deferred Tax Assets averaged around $13.1 million, with its median value being $13.1 million (2014).